Plus Therapeutics (PSTV) Intangibles (2010 - 2026)
Plus Therapeutics (PSTV) reported Intangibles of $299000.0 for Q1 2026, down 31.26% year-over-year from $435000.0 in Q1 2025, and down 10.21% quarter-over-quarter from $333000.0 in Q4 2025.
Plus Therapeutics (PSTV) Intangibles (2010 - 2026) Analysis & Trends
Plus Therapeutics (PSTV) has 17 years of Intangibles data on file, last reported at $299000.0 in Q1 2026.
- Intangibles for Q1 2026 came in at $299000.0, down 31.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $299000.0 (down 31.26% YoY), and the FY2025 annual result was $333000.0, down 29.0% from the prior year.
- Intangibles retreated to $299000.0 in Q1 2026 per PSTV's latest filing, from $333000.0 in the prior quarter.
- Over five years, Intangibles peaked at $557000.0 in Q2 2024 and troughed at $33000.0 in Q1 2024.
- A 5-year average of $243294.1 and a median of $150000.0 in 2022 frame the typical range for Intangibles.
- The sharpest annual moves came in 2024 and 2025: Intangibles plunged 58.23% in 2024, then jumped 1218.18% in 2025.
- A 5-year view of Intangibles shows it stood at $94000.0 in 2022, then slumped by 55.32% to $42000.0 in 2023, then soared by 1016.67% to $469000.0 in 2024, then declined by 29.0% to $333000.0 in 2025, then declined by 10.21% to $299000.0 in 2026.
- Business Quant data shows PSTV's Intangibles at $299000.0 in Q1 2026, $333000.0 in Q4 2025, and $374000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 4.41 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 418.50 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 7.73 Mn |
| 10 | Plus Therapeutics | 37.48 Mn | 22.37 Mn | - | 299,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 299,000.00 |
| Dec 31, 2025 | 333,000.00 |
| Sep 30, 2025 | 374,000.00 |
| Jun 30, 2025 | 401,000.00 |
| Mar 31, 2025 | 435,000.00 |
| Dec 31, 2024 | 469,000.00 |
| Sep 30, 2024 | 513,000.00 |
| Jun 30, 2024 | 557,000.00 |
| Mar 31, 2024 | 33,000.00 |
| Dec 31, 2023 | 42,000.00 |
| Sep 30, 2023 | 49,000.00 |
| Jun 30, 2023 | 64,000.00 |
| Mar 31, 2023 | 79,000.00 |
| Dec 31, 2022 | 94,000.00 |
| Sep 30, 2022 | 113,000.00 |
| Jun 30, 2022 | 131,000.00 |
| Mar 31, 2022 | 150,000.00 |
| Dec 31, 2021 | 51,000.00 |
| Sep 30, 2021 | 60,000.00 |
| Jun 30, 2021 | 69,000.00 |